J&J | Des Atouts



Assets Changement Date
AbbVie USD 136.17B 1B 2025-03
Abbott USD 84B 2.55B 2025-06
Amgen USD 87.9B 1.47B 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Baxter International USD 21.3B 4.48B 2025-03
Bayer EUR 105.24B 3.95B 2025-06
Becton, Dickinson and Co. USD 54.9B 435M 2025-06
Biogen USD 28.33B 297.1M 2025-06
Boston Scientific USD 40.14B 745M 2025-03
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
CONMED USD 2.33B 30.78M 2025-06
Cooper Companies USD 12.41B 191.4M 2025-04
Dexcom USD 7.33B 575.3M 2025-06
Edwards Lifesciences USD 13.02B 33M 2025-03
Eli Lilly USD 100.92B 11.53B 2025-06
Gilead Sciences USD 55.72B 713M 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Globus Medical USD 4.96B 249.94M 2025-06
Hologic USD 8.81B 261M 2025-06
Insulet USD 3.47B 48.1M 2025-06
Integra LifeSciences USD 3.67B 384.85M 2025-06
Intuitive Surgical USD 20.16B 942.8M 2025-06
J&J USD 193.67B 13.57B 2025-03
Medtronic USD 91.68B 1.71B 2025-04
Merck USD 117.52B 2.4B 2025-06
Merit Medical Systems USD 2.59B 118.07M 2025-06
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 206.1B 1.93B 2025-06
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 124.96B 6.93B 2025-06
Stryker USD 46.33B 325M 2025-06
Tandem Diabetes Care USD 875.74M 46.41M 2025-06
Teva Pharmaceutical Industries USD 40.13B 1.72B 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06
Zimmer Biomet Holdings USD 22.87B 681.2M 2025-06
Zoetis USD 14.48B 381M 2025-06


J&J Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.